Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00143598 · ClinicalTrials.gov registry record · Phase 3
The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome
A Phase 3 study of Deep Venous Thrombosis, sponsored by Sir Mortimer B. Davis - Jewish General Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 806
- Enrollment target
- 20
- Study locations
NCT00143598 is a Phase 3 study of Deep Venous Thrombosis that has completed, run by Sir Mortimer B. Davis - Jewish General Hospital. The registered enrollment target is 806 participants, above the 377-participant average among 9 other Deep Venous Thrombosis trials with a reported enrollment target (114% higher). The trial reports 20 study locations across 8 states.
The verdict
NCT00143598, a Phase 3 study of Deep Venous Thrombosis, has completed, sponsored by Sir Mortimer B. Davis - Jewish General Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 806 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether elastic compression stockings used for 2 years are effective in preventing the post-thrombotic syndrome in patients with symptomatic proximal deep venous thrombosis.
Conditions Studied
Interventions
- DEVICE Knee-length, graduated elastic compression stocking
- DEVICE Knee-length, placebo stocking
Study Locations (20)
Ontario
- Hamilton Health Sciences - General Hospital - Hamilton
- Hamilton Health Sciences - Chedoke Division - Hamilton
- Hamilton Health Sciences - McMaster University Medical Centre - Hamilton
- St. Joseph's Healthcare Hamilton - Hamilton
- Hamilton Health Sciences - Henderson General Hospital - Hamilton
- London Health Sciences Centre - London
- The Ottawa Hospital, Civic Campus - Ottawa
- Sunnybrook & Women's College Health Sciences Centre - Toronto
- University Health Network - Toronto General Hospital - Toronto
Quebec
- Centre Hospitalier Pierre-Boucher - Longueuil
- Hôpital Maisonneuve-Rosemont - Montreal
- Centre Hospitalier de l'Université de Montréal - Hôpital Notre-Dame - Montreal
- Centre Hospitalier de l'Université de Montréal - Hôpital Hôtel-Dieu - Montreal
- Royal Victoria Hospital - McGill University Health Centre - Montreal
Michigan
- Henry Ford Health Systerm - Detroit
North Carolina
- Duke University Medical Center - Durham
Oklahoma
- Oklahoma University Health Sciences Center - Oklahoma City
British Columbia
- Victoria Heart Institute Foundation - Victoria
Manitoba
- St. Boniface General Hospital - Winnipeg
Nova Scotia
- QE II Health Sciences Centre - Halifax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 806 participants |
| Start Date | 2004-06 |
| Est. Completion | 2012-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00143598
The ClinicalTrials.gov registry entry for NCT00143598 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 806 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 377-participant average among 9 other Deep Venous Thrombosis trials with a reported enrollment target (114% higher). The listed sponsor is Sir Mortimer B. Davis - Jewish General Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Deep Venous Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which Knee-length, graduated elastic compression stocking is the first listed.
NCT00143598 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Ontario, Quebec, Michigan.
Frequently Asked Questions
What is clinical trial NCT00143598 about?
NCT00143598 is a clinical study titled "The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome". The purpose of this study is to determine whether elastic compression stockings used for 2 years are effective in preventing the post-thrombotic syndrome in patients with symptomatic proximal deep venous thrombosis.
What is the current status of trial NCT00143598?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 806 participants. The study started on 2004-06. Estimated completion is 2012-02.
What conditions does trial NCT00143598 study?
This clinical trial studies the following conditions: Deep Venous Thrombosis.
What interventions are being tested in trial NCT00143598?
The interventions under investigation include: Knee-length, graduated elastic compression stocking (DEVICE), Knee-length, placebo stocking (DEVICE).
Who is sponsoring clinical trial NCT00143598?
This trial is sponsored by Sir Mortimer B. Davis - Jewish General Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00143598 being conducted?
This trial has 20 study locations across Michigan, North Carolina, Oklahoma, British Columbia, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deep Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
ACTIVE NOT RECRUITING · Phase 3
-
Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
COMPLETED · Phase 3
-
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
RECRUITING · NA
-
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
RECRUITING · Phase 2
-
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
RECRUITING · NA
-
FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.